Back
Armata Pharmaceuticals, Inc. 10K Form
Sell
37
ARMP
Armata Pharmaceuticals, Inc.
Last Price:
$5.83
Seasonality Move:
17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARMP News And Ratings
See the #1 stock for the next 7 days that we like better than ARMP
ARMP Financial Statistics
Sales & Book Value
| Annual Sales: | $5.2M |
|---|---|
| Cash Flow: | $-4.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.64 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.32300 |
|---|---|
| Net Income (TTM): | $-46.9M |
| Gross Margin: | $3.8M |
| Return on Equity: | 0% |
| Return on Assets: | -51.53% |
Armata Pharmaceuticals, Inc. Earnings Forecast
Key Armata Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 31 years for ARMP is 74.39%.
-
The Selling, General & Administrative Expenses for ARMP have been equal to 254.81% of Gross Profit Margin.
-
The Research & Development expenses have been 665.37% of Revenue.
-
The Net Earning history of ARMP is -365.60% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 15 years.
Armata Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARMP |
| CUSIP: | 04216R |
| Website: | armatapharma.com |
Debt
| Debt-to-Equity Ratio: | -1.86 |
|---|---|
| Current Ratio: | 0.12 |
| Quick Ratio: | 0.11 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ARMP Technical Analysis vs Fundamental Analysis
Sell
37
Armata Pharmaceuticals, Inc. (ARMP)
is a Sell
Is Armata Pharmaceuticals, Inc. a Buy or a Sell?
-
Armata Pharmaceuticals, Inc. stock is rated a SellThe current Armata Pharmaceuticals, Inc. [ARMP] share price is $5.99. The Score for ARMP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.